Prevalence of FOB testing in eastern-Australian general practice patients: what has a national bowel cancer screening program delivered?
- PMID: 25818504
- DOI: 10.1071/HE14058
Prevalence of FOB testing in eastern-Australian general practice patients: what has a national bowel cancer screening program delivered?
Abstract
Issues addressed: The National Bowel Cancer Screening Program (NBCSP) was introduced in Australia in 2006, offering free immunochemical Faecal Occult Blood Test (FOBT) to persons aged 50, 55 or 65. The study aimed to examine the prevalence of self-reported screening for colorectal cancer (CRC) using the FOBT and factors associated with not having an FOBT.
Methods: A cross-sectional study of Australian general practice patients aged 50 and over with no personal history of CRC completed a health risk survey while waiting for scheduled appointments between November 2010 and November 2011.
Results: A total of 5671 patients from 12 practices were approached to participate. Of the 4707 eligible patients (adults attending for care who understood English and were capable of providing informed consent), 4062 (86%) consented to participate, with 2269 eligible to complete the FOBT items. Approximately half (52%) of participants reported ever having an FOBT. More than one-third (39.7%) of the sample reported having an FOBT in the prior three years. Those who recalled receiving a mailed kit as part of the NBCSP were five times more likely to report being screened. Those less likely to report screening were aged 50-59 years, were female and had been diagnosed with a form of cancer other than CRC.
Conclusions: There is justification for the extension of the NBCSP to ensure a majority of the age-appropriate population is screened for CRC. SO WHAT?: Further work is needed to identify whether high rates of screening are achievable using the mailed-kit approach, and how to increase participation by females, those aged 50-69 years and those diagnosed with other cancers.
Similar articles
-
Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.Aust Health Rev. 2018 Feb;42(1):45-52. doi: 10.1071/AH16126. Aust Health Rev. 2018. PMID: 28248632
-
Testing the effectiveness of a general practice intervention to improve uptake of colorectal cancer screening: a randomised controlled trial.Aust N Z J Public Health. 2019 Oct;43(5):464-469. doi: 10.1111/1753-6405.12913. Epub 2019 Jul 3. Aust N Z J Public Health. 2019. PMID: 31268211 Clinical Trial.
-
Prevalence of appropriate colorectal cancer screening and preferences for receiving screening advice among people attending outpatient clinics.Aust N Z J Public Health. 2018 Aug;42(4):334-339. doi: 10.1111/1753-6405.12776. Epub 2018 Mar 12. Aust N Z J Public Health. 2018. PMID: 29528551
-
[Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].Gastroenterol Hepatol. 2009 Oct;32(8):565-76. doi: 10.1016/j.gastrohep.2009.01.179. Epub 2009 Jul 3. Gastroenterol Hepatol. 2009. PMID: 19577340 Review. Spanish.
-
Australia's national bowel cancer screening program: does it work for indigenous Australians?BMC Public Health. 2010 Jun 25;10:373. doi: 10.1186/1471-2458-10-373. BMC Public Health. 2010. PMID: 20579344 Free PMC article. Review.
Cited by
-
Testing the Effectiveness of a Primary Care Intervention to Improve Uptake of Colorectal Cancer Screening: A Randomized Controlled Trial Protocol.JMIR Res Protoc. 2017 May 10;6(5):e86. doi: 10.2196/resprot.7432. JMIR Res Protoc. 2017. PMID: 28490420 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical